Stocks

TILT Holdings is partnering with Long Island, New York’s Shinnecock Indian Nation to establish vertical cannabis operations on their tribal territory in the Hamptons.

Tilray has acquired the majority of outstanding senior secured convertible notes of MedMen, setting the Canadian firm up to obtain a “significant equity position” in the U.S.-based MSO.

PharmaCann is planning an initial public offering that could value the company at over $1 billion, according to a Reuters report.

Leafly announced on Monday it plans to go public on the NASDAQ via a reverse takeover with Merida Merger Corp.

Green Thumb Industries last week acquired Dharma Pharmaceuticals, one of Virginia’s four medical cannabis processing companies and the only cannabis producer in Southwest Virginia.

Former CannTrust officials have been charged for making efforts to conceal the illegal growing of cannabis at CannTrust facilities over a 10-month period—the investigation ultimately forced the company to destroy $65 million worth of inventory.

Weedmaps Holding Company LLC on Wednesday began trading on the Nasdaq following a takeover of Silver Spike Acquisition Corp.

Cannabis operator Columbia Care Inc announced on Tuesday a deal to acquire Medicine Man Denver for $42 million in cash and stock.

Cronos Group Inc. announced on Monday it had reached a deal with Pharmacann that would allow a subsidiary to acquire a potential 10.5% ownership stake in the cannabis operator.

The cannabis-focused venture capital firm Oxford Cannabinoid Technologies — which is backed by Casa Verde, the venture capital firm partially owned by Snoop Dogg — started trading today on the London Stock Exchange.

Canadian cannabis company Flora Growth Corp., which cultivates medical cannabis in Colombia, started trading yesterday on the Nasdaq market.

Credit Suisse Group AG is said to be no longer trading or holding shares of cannabis firms with U.S. operations.

Canadian cannabis companies Tilray and Aphria have finished their merger to become the world’s largest cannabis company based on pro forma revenue.

Green Thumb Industries is reportedly the subject of a federal investigation over possible pay-to-play violations during the licensing process. The company called the allegations baseless and said it is unaware of any such investigation.

The SEC announced fraud charges on Monday against Irvine, California-based stock trader Andrew L. Fassari for allegedly using Twitter to spread lies about and drive up the stock price of a now-defunct cannabis company.

Verano Holdings in Chicago is facing a RICO lawsuit for allegedly having an employee illegally transport cannabis clippings from Illinois to Arkansas. The company has called the charges “totally false and absurd.”

Curaleaf Holdings is set to acquire EMMAC Life Sciences Ltd., Europe’s largest vertically integrated cannabis company, for approximately $286 million.

An influential Democrat from Kentucky is accused of unethical stock purchases after buying up multiple cannabis stocks prior to endorsing the MORE Act, which was passed by the House in December.

Cannabis company Parallel has entered into an acquisition agreement with Ceres Acquisition Corp that would see the combined company go public.

Chicago-based Verano Holdings Corp. is now trading on the Canadian Securities Exchange following its reverse takeover of Majesta Minerals Inc. on Wednesday.

WallStreetBets, the Reddit-based forum behind the “GameStonk” phenomenon that rocked the stock market last month, set its sights this week on the cannabis space.

GW Pharmaceuticals, creator of the first FDA-approved medication made from cannabis, is set to be purchased by Jazz Pharmaceuticals in a $7.2 billion cash-and-stock deal.

Cannabis grow tech company Agrify began trading on the Nasdaq last week; the company is not a plant-touching business but provides cultivation solutions for professional indoor cannabis growers.

Anticipating accelerated cannabis reforms around the country, Curaleaf Holdings yesterday announced an offering of 16.5 million subordinate voting shares at C$16.70 per share.